Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oncogene expression in related cancer lines differing in metastatic capacity

Abstract

Various murine tumor cell lines with different metastatic capacities were testedin vitro for oncogene expression, especially of the p21-Ha-ras protein. Small differences were seen in the expression of several distinct oncogenes in the case of a high metastatic lymphoma variant (ESb) and its low metastatic parental line (Eb). In one instance we observed a 30-fold Ha-ras gene amplification in a metastasis-derived cell line from a spontaneous mouse mammary carcinoma. In spite of this amplification we did not find an increased p21 expression in these cells.

This is a preview of subscription content, log in to check access.

References

  1. [1]

    Alitalo, K., 1984, Amplification of cellular oncogenes in cancer cells.Medical Biology (Helsinki),62, 304–317.

  2. [2]

    Benke, R.,Lang, E.,Komitowski, D.,Muto, S., andSchirrmacher, V., 1987, Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth.Invasion and Metastasis (in press).

  3. [3]

    Bernstein, S. C., andWeinberg, R. A., 1985, Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA.Proceedings of the National Academy of Sciences, U.S.A.,82, 1726–1730.

  4. [4]

    Bishop, J. M., 1983, Cellular oncogenes and retroviruses.Annual Reviews in Biochemistry,52, 301–354.

  5. [5]

    Bondy, G. P., Wilson, S., andChambers, A. F., 1985, Experimental metastatic ability of H-ras-transformed NIH 3T3 cells.Cancer Research,45, 6005–6009.

  6. [6]

    Bradley, M. O., Kraynak, A., andStorer, R. P., 1986, Transfection of myc and ras into rat cells rapidly induces a metastatic phenotype without selection.Proceedings of the Annual Meeting of the American Association for Cancer Research,27, 62.

  7. [7]

    Bradley, M. O., Kraynak, A. R., Storer, R. D., andGibbs, J. B., 1986, Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.Proceedings of the National Academy of Sciences, U.S.A.,83, 5277–5281.

  8. [8]

    Curran, T., Peters, G., van Beveren, C., Teich, N. M., andVerma, I., 1982, FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.Journal of Virology,44, 674–682.

  9. [9]

    Dolnick, B. J., andReznikoff, C. A., 1984, Amplification of the Ha-ras oncogene correlates with the malignant properties of several rodent cell linesin vitro and is associated with a clinical metastatic bladder carcinoma.Proceedings of the Annual Meeting of the American Association for Cancer Research,25, 65.

  10. [10]

    Donner, L., Fedele, L. A., Garon, C. F., Anderson, S. J., andSherr, C. J., 1982, McDonough feline sarcome virus: characterisation of the molecularly cloned provirus and its feline oncogene (v-fms).Journal of Virology,41, 489–500.

  11. [11]

    Dzarlieva, R., Schirrmacher, V., andFusenig, N. F., 1982, Cytogenic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system.International Journal of Cancer,30, 633–642.

  12. [12]

    Ellis, R. W., DeFeo, D., Shih, T. Y., Gonda, M. A., Young, H. A., Tsuchida, N., Lowy, D. R., andScolnick, E. M., 1981, The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.Nature,292, 506–511.

  13. [13]

    Fogel, M., Altevogt, P., andSchirrmacher, V., 1983, Metastatic potential severely altered by changes in tumor cell adhesiveness and cell surface sialylation.Journal of Experimental Medicine,157, 371–376.

  14. [14]

    Furth, M. E., Davis, L. J., Fleurdelys, B., andScolnick, E. M., 1982, Monoclonal antibody to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.Journal of Virology,43, 294–304.

  15. [15]

    Gallick, G. E., Kurzrock, R., Kloetzer, W. S., Arlinghaus, R. B., andGutterman, J. U., 1985, Expression of p21ras in primary amd metastatic human colorectal tumors.Proceedings of the National Academy of Sciences, U.S.A.,82, 1795–1799.

  16. [16]

    Gelmann, E. P., Wong-Staal, F., Kramer, R. A., andGallo, R. C., 1981, Molecular cloning and comparative analyses of simian sarcoma virus and its associated helper virus.Proceedings of the National Academy of Sciences, U.S.A.,78, 3373–3377.

  17. [17]

    Glover, M. D., (editor), 1985,DNA Cloning, Vol. 1:A Practical Approach (London: IRL Press).

  18. [18]

    Glover, M. D., (editor), 1985,DNA Cloning, Vol. 2:A Practical Approach (London: IRL Press).

  19. [19]

    Goff, S. P., Gilboa, E., Witte, O. N., andBaltimore, D., 1980, Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.Cell,22, 777–785.

  20. [20]

    Greig, G., Koestler, T. P., Trainer, D. L., Corwin, S. P., Miles, L., Kline, T., Sweet, R., Yokoyama, S., andPoste, G., 1985, Tumorigenic and metastatic properties of ‘normal’ and ras-transfected NIH 3T3 cells.Proceedings of the National Academy of Sciences, U.S.A.,82, 3698–3701.

  21. [21]

    Kahn, P., andGraf, T. (editor), 1986,Oncogenes and Growth Control (Berlin: Springer Verlag).

  22. [22]

    Kerbel, R. S., Dennis, J. W., Lagarde, A. E., andFrost, P., 1982, Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.Cancer Metastasis Reviews,1, 99–140.

  23. [23]

    Kerr, I. B., Spandidos, D. A., Finlay, I. G., Lee, F. P., andMcArdle, C. S., 1986, The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma.British Journal of Cancer,53, 231–235.

  24. [24]

    Klein, G., Sjögren, H. O., Klein, E., andHellström, K. E., 1960, Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.Cancer Research,20, 1561–1572.

  25. [25]

    Kris, R. M., Avivi, A., Bar-Eli, M., Alon, Y., Carmi, P., Schlessinger, J., andRaz, A., 1985, Expression of ki-ras oncogene in tumor cell variants exhibiting different metastatic capabilities.International Journal of Cancer,35, 227–230.

  26. [26]

    Kurzrock, R., Gallick, G. E., andGutterman, J. U., 1984, Expression of ras gene products in primary and metastatic human colorectal tumors.Proceedings of the Annual Meeting of the American Association for Cancer Research,25, 66.

  27. [27]

    Land, H., Parada, L. F., andWeinberg, R. A., 1983, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.Nature,304, 596–602.

  28. [28]

    Larizza, L., Schirrmacher, V., andPflüger, E., 1984, Acquisition of high metastatic capacity afterin vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.Journal of Experimental Medicine,160, 1579–1584.

  29. [29]

    Maniatis, T., Fritsch, E. F., andSambrock, J., 1982,Molecular Cloning (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory).

  30. [30]

    Mareel, M. M., andvan Roy, F. M., 1986, Are oncogenes involved in invasion and metastasis?Anticancer Research,6, 419–436.

  31. [31]

    Muschel, R. J., Williams, J. E., Lowy, D. R., andLiotta, L. A., 1985, Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.American Journal of Pathology,121, 1–8.

  32. [32]

    Nicolson, G. L., 1984, Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.Clinical and Experimental Metastasis,2, 85–105.

  33. [33]

    Oosterhuis, J. W., de Jong, B., van Dalen, I., van der Meer, I., Visser, M., de Leij, L., Mesander, G., Collard, J. G., Koops, H. S., andSleijfer, D. T., 1985, Identical chromosome translocation in four metastases of a mediastinal teratocarcinoma.Cancer Genetics and Cytogenetics,15, 99–107.

  34. [34]

    Parr, I., 1972, Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumor.British Journal of Cancer,26, 174–182.

  35. [35]

    Perbal, B., andBaluda, M. A., 1982, Avain myeloblastosis virus transforming gene is related to unique chicken DNA regions separated by at least one intervening sequence.Journal of Virology,41, 250–257.

  36. [36]

    Pozzatti, R., Muschel, R., Williams, J., Padmanabhan, R., Howard, B., Liotta, L., andKhoury, G., 1986, Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials.Science,232, 223–227.

  37. [37]

    Rapp, U. R., Goldborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., Jr, andStephenson, J. R., 1983, Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.Proceedings of the National Academy of Sciences, U.S.A.,80, 4218–4222.

  38. [38]

    Reddy, E. P., Reynolds, R. K., Santos, E., andBarbacid, M., 1982, A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.Nature,300, 149–152.

  39. [39]

    Rotter, V., Wolf, D., Blick, M., andNicolson, G. L., 1985, Expression of abl and other oncogenes is independent of metastatic potential in Abelson virus transformed malignant murine large cell lymphoma.Clinical and Experimental Metastasis,3, 77–86.

  40. [40]

    Schirrmacher, V., 1985, Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies.Advances in Cancer Research,43, 1–73.

  41. [41]

    Schirrmacher, V., andBarz, D., 1986, Characterization of cellular and extracellular plasma membrane vesicles from a low metastatic lymphoma (Eb) and its high metastatic variant (ESb): inhibitory capacity in cell-cell interaction systems.Biochimica et Biophysica Acta,860, 236–242.

  42. [42]

    Schirrmacher, V., Fogel, M., Russmann, E., Bosslet, K., Altevogt, P., andBeck, L., 1982, Antigenic variation in cancer metastasis: immune escape versus immune control.Cancer Metastasis Reviews,1, 241–274.

  43. [43]

    Schirrmacher, V., Shantz, G., Clauer, K., Komitowski, D., Zimmermann, H.-P., andLohmann-Matthes, M.-L., 1979, Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasivenessin vitro and metastasis formationin vivo.International Journal of Cancer,23, 233–244.

  44. [44]

    Sherr, C. J., Fedele, L. A., Oskarsson, M., Maizel, J., andVande Woude, G., 1980, Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus.Journal of Virology,34, 200–212.

  45. [45]

    Stephens, R. M., Rice, N. R., Hiebisch, R. R., Bose, H. R., Jr, andGilden, R. V., 1983, Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.Proceedings of the National Academy of Sciences, U.S.A.,80, 6229–6233.

  46. [46]

    Thorgeirsson, U. P., Turpeenniemi-Hujanen, T., Williams, J. E., Westin, E. H., Heilman, C. A., Talmadge, J. E., andLiotta, L. A., 1985, NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice.Molecular and Cellular Biology,5, 259–262.

  47. [47]

    van de Velde, C. J. H., 1977, A new metastasizing mammary carcinoma model in mice: model characteristics and applications. In:Model Studies on Breast Cancer Treatment, Publication of the Radiobiological Institute of the Organization for Health Research, The Netherlands, pp. 71–89.

  48. [48]

    Vennström, B., Fanshier, L., Moscovici, C., andBishop, J. M., 1980, Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells.Journal of Virology,36, 575–585.

  49. [49]

    Vousden, K. H., Eccles, S. A., Purvies, P., andMarshall, C. J., 1986, Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene.International Journal of Cancer,37, 425–433.

  50. [50]

    Vousden, K. H., andMarshall, C. J., 1984, Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma.EMBO Journal,5, 913–917.

  51. [51]

    Watson, D. K., Psallidopoulos, M. C., Samuel, K. P., Dalla-Favera, R., andPapas, T. S., 1983, Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC 29 transforming gene reveals a highly conserved gene product.Proceedings of the National Academy of Sciences, U.S.A.,80, 3642–3645.

  52. [52]

    Weinberg, R. A., 1985, The action of oncogenes in the cytoplasm and nucleus.Science,230, 770–776.

  53. [53]

    Yokota, J., Tsunetsugu-Yokota, Y., Battifora, H., LeFevre, C., andCline, M. J., 1986, Alterations of myc, myb and rasHa protooncogenes in cancer are frequent and show clinical correlation.Science,231, 261–265.

  54. [54]

    Yoshida, M., Kawai, S., andToyoshima, K., 1981, Genome structure of avian sarcoma virus Y73 and unique sequence coding for polyprotein p90.Journal of Virology,38, 430–437.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pohl, J., Radler-Pohl, A., Heicappell, R. et al. Oncogene expression in related cancer lines differing in metastatic capacity. Clin Exp Metast 6, 201–211 (1988). https://doi.org/10.1007/BF01782480

Download citation

Keywords

  • Lymphoma
  • Tumor Cell Line
  • Parental Line
  • Gene Amplification
  • Mammary Carcinoma